• Journal of Radiation Protection and Research
• /
• 제14권2호
• /
• pp.10-17
• /
• 1989

옥외 라돈이 호흡기관에 주는 선량을 측정 평가할 목적으로 CR-39 비적검출기를 내장한 라돈컵을 사용하여 대기중 라돈농도를 측정하였다. 직접헝 검출기 및 개방 컵과 필터 컵의 구조를 갖는 CR-39 비적검출기에 대한 라돈검출인자는 공기중의 농도가 잘 알려진 표준라돈 조사시설에서 이들 검출기와 라돈컵을 일정기간 조사하여 결정하였다. CR-39를 $70^{\circ}C$, 30% NaOH 용액으로 220분간 화학부식하였을 때 직접형 검출기와 개방 컵, 필터 컵에 대한 라돈검출인자는 각각 0.273, 0.0813, 0.0371 tr $mm^{-2}/(37\;Bqm^{-3}{\cdot}d)$였다. 또한 1988년 5월에서 1989년 3월까지 대전(충남대학교)에서 측정한 대기중의 라돈농도는 개방 컵에 의한 결과는 27.4 - 135.8 $Bq/m^3$ (0.74 - 3.67 pCi/l)로서 연평균 73.3Bq/$m^3$ (1.98pCi/l)이었으며, 필터 컵에 의한 결과는 16.7 - 143.9 Bq/$m^3$ (0.45 - 3.89pCi/l)로 연평균 68.5 Bq/$m^3$ (1.85 pCi/l)이었다. 측정한 옥외 대기중의 라돈농도와 부위별 폐선량모형으로 부터 산출한 ICRP 표준인의 호흡기관에 대한 실효 선량당량률은 약 520 nSv/h로 평가되었다.

• 한국방사성폐기물학회:학술대회논문집
• /
• 한국방사성폐기물학회 2019년도 춘계학술논문요약집
• /
• pp.349-350
• /
• 2019

• Journal of Radiation Protection and Research
• /
• 제12권2호
• /
• pp.37-50
• /
• 1987

The exposure of the population in the United States to ionizing radiation has recently been evaluated by the National Council on Radiation Protection and Measurements (NCRP). This was done by constituting six organizational groups to address various phases of the work and the results of this work are summarized in this article. The article is based on the report, by the same title, which is scheduled for publication by the NCRP in September, 1987. The six organizational groups are titled Radiation Exposure from Consumer Products, Natural Background Radiation, Radiation Associated with Medical Examinations, Radiation Received by Radiation Employees, Public Exposure from Nuclear Power, and Exposure from Miscellaneous Environmental Sources. These titles are descriptive of the subject areas covered by each of these separate groups. The data evaluated are for the years 1977-1984 with the majority of the data being for the period 1980-1982. Summary information is presented and discussed for the number of people exposed to given sources, the effective dose equivalent, the average effective dose equivalent to the U.S. population, and the genetically significant dose equivalent. The average annual effective dose equivalent from all sources to the U.S. population is approximately 3.6 mSv (360 mrem). Exposures to natural sources make the largest contribution to this total. Radon and radon decay products contribute 2.0 mSv (200 mrem) whereas the other naturally occurring radionuclides contribute 1.0 mSv (100 mrem). Among man-made or enhanced sources, medical exposures make the largest additional contributions, namely 0.39 mSv (39 mrem) for diagnosis and 0.14 mSv (14 mrem) for nuclear medicine. It was not possible to evaluate exposures for therapy. Most of the other sources of population exposure, including nuclear power and consumer products, are minor. A possible exception would be the use of tobacco products. These exposures are discussed in relation to a negligible individual risk level of $10{\mu}Sv/y$ (1 mrem/y). The NCRP considers exposures below the negligible individual risk level as trivial and as such should be dismissed.

• Journal of Radiation Protection and Research
• /
• 제43권1호
• /
• pp.29-38
• /
• 2018

Background: Radon contributing about 42% of annual average dose, mainly comes from soil. In this paper, standard measurement procedures for soil radon exhalation rate are suggested and their measurement uncertainties are analyzed. Materials and Methods: We used accumulation method for estimating surface exhalation rate. The closed-loop measurement system was made up with a RAD7 detector and a surface chamber. Radon activity concentrations in the system were observed as a function of time, with data collection of 5 and 15-minute and the measurement time of 4 hours. Linear and exponential fittings were used to obtain radon exhalation rates from observed data. Standard deviations of measurement uncertainties for two approaches were estimated using usual propagation rules. Results and Discussion: The exhalation rates (E) from linear approach, with 30 minutes measurement time were $44.8-48.6mBq{\cdot}m^{-2} {\cdot}s^{-1}$ or $2.14-2.32atom{\cdot}cm^{-2}{\cdot}s^{-1}$ with relative measurement uncertainty of about 10%. The contributions of fitting parameter A, volume (V) and surface (S) to the estimated measurement uncertainty of E were 59.8%, 30.1% and 10.1%, in average respectively. In exponential fitting, at 3-hour measurement we had E ranged of $51.6-69.2mBq{\cdot}m^{-2} {\cdot}s^{-1}$ or $2.46-3.30atom{\cdot}cm^{-2}{\cdot}s^{-1}$ with about 15% relative uncertainty. Fitting with 4-hour measurement resulted E about $51.3-68.2mBq{\cdot}m^{-2} {\cdot}s^{-1}$ or $2.45-3.25atom{\cdot}cm^{-2}{\cdot}s^{-1}$ with 10% relative uncertainty. The uncertainty contributions in exponential approach were 75.1%, 13.4%, 8.7%, and 2.9% for total decay constant k, fitting parameter B, V, and S, respectively. Conclusion: In obtaining exhalation rates, the linear approach is easy to apply, but by saturation feature of radon concentrations, the slope tends to decrease away from the expected slope for extended measurement time. For linear approach, measurement time of 1-hour or less was suggested. For exponential approach, the obtained exhalation rates showed similar values for any measurement time, but measurement time of 3-hour or more was suggested for about 10% relative uncertainty.

• Journal of Radiation Protection and Research
• /
• 제14권2호
• /
• pp.23-29
• /
• 1989

이중관 형태의 라돈 표준선원을 제작하여 루카스셀의 계수치 (cph)를 라돈농도로 나타내기 위한 환산인자를 측정한 결과 라돈 표준선원을 실온으로 하였을 때는 0.031$\pm$0.001 (pCi/l)/(cph/Cell)였다. 사무실 내에서 라돈과 라돈 자핵종의 농도를 측정한 값은 $^{222}Rn,\;{\rightarrow}^{218}Po\;{\rightarrow}^{214}Pb,\;{\rightarrow}^{214}Bi$ 의 평균 농도가 각각 0.87, 0.53, 0.35, 0.26 pCi/l 였다. 이때 전체 방사평형인자와 WL의 평균 값은 각각 0.40, 3.33${\times}10^{-3}$ 이며 측정 지점에서 연간 피폭되는 방사선량으로 환산하면 약 30 mren 이다.

• 한국방사선학회논문지
• /
• 제5권5호
• /
• pp.231-235
• /
• 2011

라돈($^{222}Rn$)은 지각의 암석이나 토양 또는 건축자재 중에 들어 있는 우라늄($^{238}U$)과 토륨($^{232}Th$)이 몇 단계의 방사성붕괴과정을 거친 후 생성되는 무색무취의 불활성기체로 광산이나 지하같이 밀폐된 공간에 잘 축적된다. 호흡기를 통하여 폐로 유입되고 라돈의 딸핵종이 폐나 기관지에 침적되어 폐암을 일으키는 원인이 된다. 사람의 생명을 다루는 의료기관에서의 라돈피폭은 평상시 방사선피폭량이 많은 방사선관계종사자와 면역력이 약한 환자에게 큰 위험이 될 수 있다는 판단에 이 실험을 실시하였다. 실험에 쓰인 계측기는 실시간 라돈측정기인 Professional Continuous Radon monitor이며 계측장소는 두 개의 병원 지하1층에서 지상2층까지 층별로 오전 10시부터 오후 3시까지 측정 하였다. Professional Continuous Radon monitor계측결과는 최소 14.8 Bq/$m^3$에서 최대 70.3 Bq/$m^3$로 국내기준치인 148 Bq/$m^3$이하로 나타났으며 유효선량은 최소 0.296 mSv에서 최대 1.406 mSv로 일년간 자연방사선으로부터 피폭되는 방사선량인 2.4 mSv의 10~58.3% 수준으로 나타났다.

• 대한방사선기술학회지:방사선기술과학
• /
• 제40권2호
• /
• pp.289-295
• /
• 2017

본 연구는 유방암 방사선치료 시 반대편 유방의 피부선량을 경감시키기 위해 Radon phantom을 이용하여 조직등가물질인 볼루스 5 mm, 10 mm를 적용해 종속조사면 병합치료방법(FIF)과 쐐기접선조사(Wedge 15, 30) 그리고 세기조절방사선치료계획(IMRT)을 이용하여 선량비교평가를 시행하고자 하였으며, 치료처방으로 50.4 Gy로 시행하였다. 선량비교평가 방법으로 광자극발광선량계를 이용하여 치료 부위 반대편 유방의 8곳에 부착하여 각각의 치료 계획별로 선량을 측정하였다. 연구에 이용된 광자극발광선량계 중 재현성은 3% 이내인 25개를 사용하였다. 연구 결과, FIF 치료계획에서는 볼루스 없이 측정된 결과 대비 5 mm와 10 mm 평균 감소율은 각각 37.23 cGy와 41.77 cGy이었으며, Wedge $15^{\circ}$를 이용한 치료계획에서 평균 감소율은 각각 70.69 cGy, 87.57 cGy였다. 또한 IMRT에서는 각각 67.37 cGy와 83.17 cGy의 감소율을 보여주었다. 볼루스를 이용한 결과는 모든 치료계획에서 볼루스의 두께가 증가할수록 선량 감소폭이 커지는 결과를 보여주었다.

• 한국대기환경학회:학술대회논문집
• /
• 한국대기환경학회 2002년도 춘계학술대회 논문집
• /
• pp.117-118
• /
• 2002

본 연구에서는 지하수로부터 방출된 실내라돈오염을 해석하기 위한 수학적 모델에서 모델인자들의 불확실성을 고려하고 인체축적량을 정량적으로 해석하는 PBPK모델을 사용하여 호흡을 통한 라돈의 인체축적량을 보다 현실적으로 평가하려고 한다. 우선, 전에 사용한 3 구역모델을 샤워실과 화장실을 구분하는 경계가 없다는 국내실정을 감안하여 보다 현실적으로 개량한 2-구역 모델을 개발하였다. (중략)

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권6호
• /
• pp.2979-2982
• /
• 2016

Background: High dose ionizing radiation can induce ovarian cancer, but the effect of low dose radiation on the development of ovarian cancer has not been extensively studied. We evaluated the effect of low dose radiation and total background radiation, and the radiation delivered to the ovaries during the treatment of rectosigmoid cancer and breast cancer on ovarian cancer incidence. Materials and Methods: Background radiation measurements are from Assessment of Variations in Radiation Exposure in the United States, 2011. Ovarian cancer incidence data are from the Centers for Disease Control and Prevention. Standardized incidence ratios (SIR) of ovarian cancer following breast cancer and rectosigmoid cancer are from Surveillance, Epidemiology, and End Results (SEER) data. Obesity data by US state are from the Centers for Disease Control and Prevention. Mean ages of US state populations are from the United States Census Bureau. Results: We calculated standardized incidence ratios (SIR) from Surveillance, Epidemiology, and End Results (SEER) data, which reveal that in 194,042 cases of breast cancer treated with beam radiation, there were 796 cases of ovarian cancer by 120+ months of treatment (0.41%); in 283, 875 cases of breast cancer not treated with radiation, there were 1,531 cases of ovarian cancer by 120+ months (0.54%). The difference in ovarian cancer incidence in the two groups was significant (p < 0.001, two tailed Fisher exact test). The small dose of scattered ovarian radiation (about 3.09 cGy) from beam radiation to the breast appears to have reduced the risk of ovarian cancer by 24%. In 13,099 cases of rectal or rectosigmoid junction cancer treated with beam radiation in the SEER data, there were 20 cases of ovarian cancer by 120+ months of treatment (0.15%). In 33,305 cases of rectal or rectosigmoid junction cancer not treated with radiation, there were 91 cases of ovarian cancer by 120+ months (0.27%). The difference in ovarian cancer incidence in the two groups was significant (p = 0.017, two tailed Fisher exact test). In other words, the beam radiation to rectum and rectosigmoid that also reached the ovaries reduced the risk of ovarian cancer by 44%. In addition, there was a significant inverse relationship between ovarian cancer in white women and radon background radiation (r = - 0.465. p = 0.002) and total background radiation (r = -0.456, p = 0.002). Because increasing age and obesity are risk factors for ovarian cancer, multivariate linear regression was performed. The inverse relationship between ovarian cancer incidence and radon background was significant (${\beta}=-0.463$, p = 0.002) but unrelated to age (${\beta}=-0.080$, p = 0.570) or obesity (${\beta}=-0.180$, p = 0.208). Conclusions: The reduction of ovarian cancer risk following low dose radiation may be the result of radiation hormesis. Hormesis is a favorable biological response to low toxin exposure. A pollutant or toxin demonstrating hormesis has the opposite effect in small doses as in large doses. In the case of radiation, large doses are carcinogenic. However, lower overall cancer rates are found in U.S. states with high impact radiation. Moreover, there is reduced lung cancer incidence in high radiation background US states where nuclear weapons testing was done. Women at increased risk of ovarian cancer have two choices. They may be closely followed (surveillance) or undergo immediate prophylactic bilateral salpingo-oophorectomy. However, the efficacy of surveillance is questionable. Bilateral salpingo-oophorectomy is considered preferable, although it carries the risk of surgical complications. The data analysis above suggests that low-dose pelvic irradiation might be a good third choice to reduce ovarian cancer risk. Further studies would be worthwhile to establish the lowest optimum radiation dose.

• 한국의학물리학회지:의학물리
• /
• 제32권2호
• /
• pp.25-39
• /
• 2021

Brachytherapy, along with external beam radiation therapy (EBRT), is an essential and effective radiation treatment process. In brachytherapy, in contrast to EBRT, the radiation source is radioisotopes. Because these isotopes can be positioned inside or near the tumor, it is possible to protect other organs around the tumor while delivering an extremely high-dose of treatment to the tumor. Brachytherapy has a long history of more than 100 years. In the early 1900s, the radioisotopes used for brachytherapy were only radium or radon isotopes extracted from nature. Over time, however, various radioisotopes have been artificially produced. As radioisotopes have high radioactivity and miniature size, the application of brachytherapy has expanded to high-dose-rate brachytherapy. Recently, advanced treatment techniques used in EBRT, such as image guidance and intensity modulation techniques, have been applied to brachytherapy. Three-dimensional images, such as ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography are used for accurate delineation of treatment targets and normal organs. Intensity-modulated brachytherapy is anticipated to be performed in the near future, and it is anticipated that the treatment outcomes of applicable cancers will be greatly improved by this treatment's excellent dose delivery characteristics.